Ann Epidemiol. 2013 Dec;23(12):812-4. doi: 10.1016/j.annepidem.2013.10.002.
Several observational studies have linked vitamin D deficiency with an increased risk of all cause mortality. Vitamin D deficiency is common among patients with liver diseases. In a random sample of the general population, we investigated whether the inverse association between vitamin D status and all-cause mortality could be explained by liver damage as reflected by increased levels of liver enzymes.
We included a total of 2649 persons examined in 1993e1994. Vitamin D status was assessed as serum 25-hydroxyvitamin D and liver enzyme levels were measured. Information on all-cause mortality was obtained from the Danish Central Personal Register until July 2011. Median follow-up time was 17.0 years, and there were 736 deaths.
Multivariable Cox regression analyses with age as underlying time axis and delayed entry showed lower mortality risk with higher vitamin D levels and this was essentially unaffected by adjustment for liver enzyme levels with hazard ratio, 0.96 (95% confidence interval, 0.93e0.99) for a 10 nmol/L higher vitamin D level.
The present study did not support our hypothesis that the well-known association between low vitamin D status and mortality is explained by liver damage as reflected by levels of liver enzymes.
几项观察性研究表明,维生素 D 缺乏与全因死亡率增加有关。维生素 D 缺乏在肝病患者中很常见。在一般人群的随机样本中,我们研究了维生素 D 状态与全因死亡率之间的反比关系是否可以通过肝损伤(反映为肝酶水平升高)来解释。
我们共纳入了 1993 年至 1994 年检查的 2649 人。维生素 D 状态评估为血清 25-羟维生素 D,测量肝酶水平。全因死亡率信息来自丹麦中央个人登记处,截至 2011 年 7 月。中位随访时间为 17.0 年,有 736 人死亡。
使用年龄作为基础时间轴和延迟进入的多变量 Cox 回归分析显示,较高的维生素 D 水平与较低的死亡率风险相关,并且通过调整肝酶水平,这种关联基本不受影响,危险比为 0.96(95%置信区间,0.93e0.99),维生素 D 水平每升高 10nmol/L。
本研究不支持我们的假设,即众所周知的低维生素 D 状态与死亡率之间的关联可以通过肝酶水平反映的肝损伤来解释。